
Bioorganic and Medicinal Chemistry Letters p. 3583 - 3588 (1998)
Update date:2022-08-03
Topics:
Ambler, John
Baker, Emma
Brown, Lyndon
Butler, Paul
Farr, Dave
Dunnet, Karen
Le Grand, Darren
Janus, Diana
Jones, Darryl
Menear, Keith
Mercer, Mark
Smith, Garrick
Talbot, Mark
Tweed, Morris
The chemical optimisation of CGH1668 1 is described employing an in vivo model of absorption to determine the influence on bioavailability of single point modifications to five key molecular templates. The discovery of an orally bioavailable and selective thrombin inhibitor, 24, highlights the utility of this approach.
View MoreQingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
Xinjiang Zhongtai Chemical Co., Ltd.
Contact:+86-991-8788172
Address:NO.78 XISHAN RD.URUMQI,CHINA
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Nanyang Tianhua pharmaceutical Co.,Ltd.
Contact:+8618639816203
Address:Longsheng Industrial Park
Shanghai Coupling Pharmaceutical R&D Co., Ltd.(expird)
Contact:+86 021 50106671
Address:403 Room No.4 Buiding, No. 526 Ruiqing Road, Shanghai Zhangjiang Hi-Tech Park
Doi:10.1016/j.tet.2010.05.054
(2010)Doi:10.1039/a705571d
(1997)Doi:10.1007/BF02291796
(1997)Doi:10.1021/jm00301a034
(1969)Doi:10.1039/DT9950002923
(1995)Doi:10.1021/jo060129c
(2006)